Literature DB >> 28831182

Colorectal cancer: Early MRI imaging predicts regorafenib response.

Iain Dickson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28831182     DOI： 10.1038/nrgastro.2017.125

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.

Authors:  David Cunningham; Nicola Valeri; Khurum Khan; Mihaela Rata; Dow-Mu Koh; Nina Tunariu; Jens C Hahne; George Vlachogiannis; Somaieh Hedayat; Silvia Marchetti; Andrea Lampis; Mahnaz Darvish Damavandi; Hazel Lote; Isma Rana; Anja Williams; Suzanne A Eccles; Elisa Fontana; David Collins; Zakaria Eltahir; Sheela Rao; David Watkins; Naureen Starling; Jan Thomas; Eleftheria Kalaitzaki; Nicos Fotiadis; Ruwaida Begum; Maria Bali; Massimo Rugge; Eleanor Temple; Matteo Fassan; Ian Chau; Chiara Braconi
Journal:  Gut       Date:  2017-08-08       Impact factor: 23.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.